Favil Singh
Edith Cowan University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Favil Singh.
Integrative Cancer Therapies | 2016
Gregory Levin; Kenneth Mark Greenwood; Favil Singh; Daphne Tsoi; Robert U. Newton
Background. Malignant brain tumors are unpredictable and incurable, with 5-year survival rates less than 30%. The poor prognosis combined with intensive treatment necessitates the inclusion of complementary and supportive therapies that optimize quality of life and reduce treatment-related declines in health. Exercise therapy has been shown to be beneficial in other cancer populations, but no evidence is available for brain cancer survivors. Therefore, we report results from 2 preliminary cases. Methods. Two female patients diagnosed with glioblastoma multiforme and oligodendroglioma participated in a structured and supervised 12-week exercise program. The program consisted of two 1-hour resistance and aerobic exercise sessions per week and additional self-managed aerobic sessions. Outcome measures of strength, cardiovascular fitness, and several psychological indicators (depression, anxiety, and quality of life) were recorded at baseline, after 6 weeks and at the conclusion of the intervention. Results. Exercise was well tolerated; both participants completed all 24 sessions and the home-based component with no adverse effects. Objective outcome measures displayed positive responses relating to reduced morbidity. Similar positive responses were found for psychological outcomes. Scores on the Hospital Anxiety and Depression Scale showed clinically meaningful improvements in depression and total distress. Conclusion. These findings provide initial evidence that, despite the difficulties associated with brain cancer treatment and survivorship, exercise may be safe and beneficial and should be considered in the overall management of patients with brain cancer.
Integrative Cancer Therapies | 2017
Favil Singh; Robert U. Newton; Michael K. Baker; Nigel Spry; Dennis R. Taaffe; Jeffery Thavaseelan; Daniel A. Galvão
Background: Prostatectomy is associated with short- and long-term morbidity, which includes attenuation of muscle function and deterioration of lean body mass. Physical function is a known predictor of morbidity and mortality, with initial evidence indicating that presurgical exercise is associated with fewer postsurgical complications and shorter hospitalization. The aim was to determine the feasibility of a supervised presurgical exercise program for prostate cancer (PCa) patients scheduled for prostatectomy. Methods: Ten men (68+6.4 years old) with localized PCa undertook a 6-week resistance and aerobic exercise program prior surgery. Training was undertaken twice weekly and patients were assessed at baseline, presurgery, and 6 weeks postsurgery. Outcome measures included muscle and physical performance, body composition, urinary incontinence and questionnaire. Results: Muscle strength increased by 7.5% to 24.3% (P < .05) from baseline to presurgery but decreased to pretraining levels postsurgery, except for knee extensor strength (P = .247). There were significant improvements (P < .05) in the 6-m fast walk (9.3%), 400-m walk (7.4%), and chair rise (12.3%) at presurgery. Following surgery, improvements in physical performance were maintained. There was no change in lean or fat mass prior to surgery, but lean mass declined by 2.7 kg (P = .014) following surgery. There were no adverse effects from the exercise program. Conclusions: Exercise undertaken prior to prostatectomy improved muscle and physical performance, with functional benefits maintained 6 weeks postsurgery. Presurgical exercise for PCa patients has the potential to facilitate recovery by improving physical reserve capacity, especially in men with poor muscle nd physical performance.
Clinical Colorectal Cancer | 2017
Favil Singh; Robert U. Newton; Michael K. Baker; Nigel Spry; Dennis R. Taaffe; Daniel A. Galvão
Micro‐Abstract To examine the potential benefits of exercise before rectal cancer surgery, 12 patients underwent twice‐weekly aerobic and resistance training for ˜16 weeks. Despite neoadjuvant chemoradiation treatment, results suggest exercise can improve physical attributes prior to surgery which may act to buffer some of the effects of surgery. Presurgical exercise is feasible and may facilitate recovery by enhancing physical reserve capacity. Background Localized rectal carcinoma is invasive, with surgical resection the standard treatment. The aim of this study was to determine the feasibility of a supervised presurgical exercise intervention in patients with rectal cancer prior to rectal resection. Patients and Methods Twelve patients volunteered to undertake twice‐weekly aerobic and resistance exercise for ˜16 weeks prior to surgery. At baseline, presurgery, and ˜8 weeks postsurgery, muscle strength and physical performance, body composition, quality of life, and fatigue were assessed. Results Ten patients completed training, with 80% completing more than one‐half of the exercise sessions. Muscle strength improved 9% to 29% at presurgery, although this was not statistically significant, and declined postsurgery (P < .05). Importantly, postsurgery strength levels were comparable with pretraining levels. Lean mass was preserved at presurgery despite neoadjuvant chemoradiation treatment, whereas postsurgery lean mass decreased (P < .05) compared with baseline (−3.2 ± 5.4 kg) and presurgery (−3.7 ± 5.4 kg). There were no substantial changes in quality of life or fatigue. Conclusion Presurgical exercise is feasible, leading to modest improvements in some outcomes despite chemoradiation treatment. The detrimental effects of surgery were evident, especially in relation to lean mass. As such, exercise may facilitate recovery by enhancing presurgery physical reserve capacity, thereby providing a buffer to declines following surgery.
Integrative Cancer Therapies | 2018
Favil Singh; Daniel A. Galvão; Robert U. Newton; Nigel Spry; Michael K. Baker; Dennis R. Taaffe
Background: Neoadjuvant chemoradiation treatment (CRT) in rectal cancer patients is associated with a reduction in physical capacity, lean mass and increased fatigue. As a countermeasure to these treatment-related adverse effects, we examined the feasibility and preliminary efficacy of a 10-week exercise program during CRT. Methods: Ten rectal cancer patients (7 men, aged 27-70 years, body mass index = 26.4 ± 3.8 kg/m2) receiving CRT undertook supervised resistance and aerobic exercise twice weekly. Assessments were undertaken pre- and post-intervention for upper and lower body muscle strength by 1-RM, muscle endurance, physical performance tests, body composition by dual X-ray absorptiometry, quality of life, and fatigue. Results: There was a significant loss in appendicular skeletal muscle (−1.1 kg, P = .012), and fat mass (−0.8 kg, P = .029) following CRT. Despite the loss in skeletal muscle, leg press (P = .030) and leg extension (P = .046) strength improved by 27.2% and 22.7%, respectively, and leg press endurance by 76.7% (P = .007). Changes in strength were accompanied by improved performance (P < .05) in 6-m fast walking speed (6.9%) and dynamic balance as determined by the 6-m backwards walk (15.5%). There was minimal change in quality of life and fatigue, and no adverse events related to training. Conclusions: Exercise during neoadjuvant CRT appears to be feasible and well tolerated in rectal cancer patients and may enhance physical function while minimizing adverse changes in body composition and cancer-related fatigue. These initial findings need to be confirmed in randomized controlled trials.
Cochrane Database of Systematic Reviews | 2017
Carolyn J. Peddle-McIntyre; Favil Singh; Rajesh Thomas; Robert U. Newton; Daniel A. Galvão; Vinicius Cavalheri
Background Patients with advanced lung cancer have a high symptom burden, which is often complicated by coexisting conditions. These issues, combined with the indirect effects of cancer treatment, can cumulatively lead patients to continued deconditioning and low exercise capacity. This is a concern as exercise capacity is considered a measure of whole body health, and is critical in a patients ability to participate in life activities and tolerate difficult treatments. There is evidence that exercise training improves exercise capacity and other outcomes, such as muscle force and health-related quality of life (HRQoL), in cancer survivors. However, the effectiveness of exercise training on these outcomes in people with advanced lung cancer is currently unclear. Objectives The primary aim of this review was to investigate the effects of exercise training on exercise capacity in adults with advanced lung cancer. Exercise capacity was defined as the six-minute walk distance (6MWD; in meters) measured during a six-minute walk test (6MWT; i.e. how far an individual can walk in six minutes on a flat course), or the peak oxygen uptake (i.e. VO peak) measured during a maximal incremental cardiopulmonary exercise test (CPET). The secondary aims were to determine the effects of exercise training on the force-generating capacity of peripheral muscles, diseasespecific global HRQoL, physical functioning component of HRQoL, dyspnoea, fatigue, feelings of anxiety and depression, lung function, level of physical activity, adverse events, performance status, body weight and overall survival in adults with advanced lung cancer. Search methods We searched CENTRAL, MEDLINE (via PubMed), Embase (via Ovid), CINAHL, SPORTDiscus, PEDro, and SciELO on 7 July 2018. Selection criteria We included randomised controlled trials (RCTs) which compared exercise training versus no exercise training in adults with advanced lung cancer.
Surgical Oncology-oxford | 2013
Favil Singh; Robert U. Newton; Daniel A. Galvão; Nigel Spry; Michael K. Baker
Supportive Care in Cancer | 2017
Gregory Levin; Kenneth Mark Greenwood; Favil Singh; Robert U. Newton
BJUI | 2017
Favil Singh; Robert U. Newton; Dennis R. Taaffe; Nigel Spry; David Joseph; Suzanne K. Chambers; Robert A. Gardiner; Daniel A. Galvão
Asia-pacific Journal of Clinical Oncology | 2017
Favil Singh; Daniel A. Galvão; Carolyn McIntyre; Nigel Spry; Dennis R. Taaffe; Rapheal Chee; Nicholas H. Hart; Robert U. Newton
Archive | 2015
Favil Singh; Daniel A. Galvão; Nicolas H. Hart; Nigel Spry; Robert U. Newton